PhaseBio Pharmaceuticals Inc

+0.04 (+1.01%)
Equity Financing / Related, Initial Public Offerings

PhaseBio Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

Published: 03/18/2021 02:18 GMT
PhaseBio Pharmaceuticals Inc (PHAS) - Phasebio Announces Pricing of Public Offering of Common Stock.
Pricing of an Underwritten Public Offering of 16,000,000 Shares of Common Stock at Price of $3.50 per Share.